EUVIMEDEUVIMED entdecken
Querschnittstudie

Prevalence and risk factors for abnormal glucose metabolism in first-episode and drug-naïve major depressive disorder outpatients with comorbid anxiety: A cross-sectional study from a large sample of the Chinese Han population

Huixue Xu, Liyan Liu, Qian Yang, Xin Wang, Zejun Li, Tieqiao Liu, Xiangyang Zhang

Journal of Affective Disorders · 2024

DOI: 10.1016/j.jad.2024.01.014 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Huixue Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changs…. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Hunan Provincial Innovation Foundation for Postgraduate, Fundamental Research Funds for Central Universities of the Central South University, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Both abnormal glucose metabolism and anxiety have been reported to be common in major depressive disorder (MDD). However, few studies have explored glucose disturbances in first-episode and drug-naive (FEDN) MDD patients with anxiety. The purpose of this study was to examine the prevalence and risk factors of glucose disturbance in FEND MDD patients comorbid with anxiety. METHODS: 1718 FEDN MDD patients were included in this study. The positive subscale of the Positive and Negative Syndrome Scale (PANSS), Hamilton Anxiety Rating Scale (HAMA), and Hamilton Depression Rating Scale (HAMD) were used to measure psychotic, anxiety and depressive symptoms respectively. Sociodemographic and biochemical indicators were also collected. RESULTS: The prevalence of glucose disorders in MDD patients combined with anxiety was 15.7 %, significantly higher than in MDD patients without anxiety symptoms (7.1 %). Glucose disturbances were associated with HAMD score, HAMA score, thyroid-stimulating hormone (TSH), thyroid peroxidase antibody (TPOAb), anti-thyroglobulin (TGAb), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL-C), fasting blood glucose (FBG), systolic blood pressure (SBP), diastolic blood pressure (DBP), suicide attempts, and psychotic symptoms. Further logistic regression showed that illness duration, TSH, TGAb, and TPOAb levels were correlates of glucose disturbances in MDD patients with anxiety. LIMITATIONS: No causal relationship could be drawn due to the cross-sectional design. CONCLUSIONS: Our findings suggest that TSH, TGAb and TPOAb may be promising biomarkers of glucose disturbances in MDD comorbid with anxiety, suggesting the importance of regular assessment of thyroid function parameters for abnormal glucose metabolism prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderHumansCross-Sectional StudiesOutpatientsPrevalenceAnxietyRisk FactorsThyrotropinChinaGlucoseCholesterol

Stichwörter der Autor:innen

AnxietyFirst-episode drug-naïveGlucose disturbancesMajor depressive disorder

Substanzen

ThyrotropinGlucoseCholesterol

Autor:innen und Institutionen

  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: 218212237@csu.edu.cn.
  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: liuliyan@csu.edu.cn.
  • Department of Psychology, Zhongshan City People's Hospital, China. Electronic address: brilliantgirl@yeah.net.
  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: wx9999@csu.edu.cn.
  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: 228212219@csu.edu.cn.
  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: liutieqiao123@csu.edu.cn.

Förderung

  • Hunan Provincial Innovation Foundation for Postgraduate
  • Fundamental Research Funds for Central Universities of the Central South University
  • Natural Science Foundation of Hunan Province
  • Shanxi Medical University

Zitieren

APA

Xu, H., Liu, L., Yang, Q., Wang, X., Li, Z., Liu, T., & Zhang, X. (2024). Prevalence and risk factors for abnormal glucose metabolism in first-episode and drug-naïve major depressive disorder outpatients with comorbid anxiety: A cross-sectional study from a large sample of the Chinese Han population. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.01.014

Vancouver

Xu H, Liu L, Yang Q, Wang X, Li Z, Liu T, et al. Prevalence and risk factors for abnormal glucose metabolism in first-episode and drug-naïve major depressive disorder outpatients with comorbid anxiety: A cross-sectional study from a large sample of the Chinese Han population. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.01.014

BibTeX
@article{Xu2024,
  author = {Xu, Huixue and Liu, Liyan and Yang, Qian and Wang, Xin and Li, Zejun and Liu, Tieqiao and Zhang, Xiangyang},
  title = {Prevalence and risk factors for abnormal glucose metabolism in first-episode and drug-naïve major depressive disorder outpatients with comorbid anxiety: A cross-sectional study from a large sample of the Chinese Han population},
  journal = {Journal of Affective Disorders},
  year = {2024},
  doi = {10.1016/j.jad.2024.01.014}
}
Kostenlos starten →